2024-12-28 18:41:50
RxPONDER Study Results Demonstrate that the Oncotype DX® Test Can Now Spare Chemotherapy Use in the Majority of Women with Node-positive Early-stage Breast Cancer
Corporate/ 2023-07-23
RxPONDER Study Results Demonstrate that ...

- First results from the independent SWOG Cancer Research Network-led Phase III study to be presented at the 2020 San Antonio Breast Cancer ...

PharmAbcine presents the latest data of the ongoing Phase Ib mTNBC trial at SABCS 2020
Corporate/ 2023-07-23
PharmAbcine presents the latest data of ...

DAEJEON,South Korea,Dec. 9,2020-- PharmAbcine Inc. (KOSDAQ: 208340ks),a clinical-stage biotech company focusing on the development of fully ...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release